Related Experiment Video
Updated: Aug 10, 2025

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
Collagen-Specific HSP47+ Myofibroblasts and CD163+ Macrophages Identify Profibrotic Phenotypes in Deceased Hearts
Andrii Puzyrenko1, Elizabeth R Jacobs2,3,4, Nathan Padilla3
1Department of Pathology Medical College of Wisconsin Milwaukee WI.
Insights
COVID-19 infection can cause cardiac fibrosis. Researchers found a "profibrotic phenotype" in hearts, marked by myofibroblasts, M2 macrophages, and collagen, suggesting a mechanism for heart complications in survivors.
Area of Science:
- Cardiovascular Pathology
- Virology
- Immunology
Background:
- Cardiac fibrosis is a known complication of SARS-CoV-2 infections, potentially leading to arrhythmias in survivors.
- Heat shock protein 47 (HSP47) is a key regulator of collagen synthesis and secretion, implicated in fibrotic processes.
Purpose of the Study:
- To investigate the presence and molecular mechanisms of cardiac fibrosis in individuals infected with SARS-CoV-2.
- To examine the role of HSP47 and macrophages in virus-associated cardiac fibrotic changes.
Main Methods:
- Human autopsy heart tissues from SARS-CoV-2 infected individuals and controls were analyzed.
- Immunofluorescence and immunohistochemistry were used to quantify HSP47+, CD163+ (macrophage marker), and collagen α1(I) positive cells.
- Tissue analysis focused on identifying co-localization in "hot spots".
Main Results:
- Approximately 40% of SARS-CoV-2 infected hearts exhibited "hot spots" with increased HSP47+ cells, CD163+ macrophages, and collagen α1(I) deposition.
- HSP47+ cells were identified as potential myofibroblasts, and CD163+ cells as M2 macrophages.
- These profibrotic markers were found in close proximity within the "hot spots".
Conclusions:
- The study presents the first evidence of a COVID-19-related "profibrotic phenotype" in human hearts, characterized by the in situ colocalization of myofibroblasts, M2 macrophages, and collagen.
- These findings suggest a potential mechanism for viral-mediated cardiac fibrosis and highlight the need for further research into public health and diagnostic implications.
Abstract:
Background Cardiac fibrosis complicates SARS-CoV-2 infections and has been linked to arrhythmic complications in survivors. Accordingly, we sought evidence of increased HSP47 (heat shock protein 47), a stress-inducible chaperone protein that regulates biosynthesis and secretion of procollagen in heart tissue, with the goal of elucidating molecular mechanisms underlying cardiac fibrosis in subjects with this viral infection. Methods and Results Using human autopsy tissue, immunofluorescence, and immunohistochemistry, we quantified Hsp47+ cells and collagen α 1(l) in hearts from people with SARS-CoV-2 infections. Because macrophages are also linked to inflammation, we measured CD163+ cells in the same tissues. We observed irregular groups of spindle-shaped HSP47+ and CD163+ cells as well as increased collagen α 1(I) deposition, each proximate to one another in "hot spots" of ≈40% of hearts after SARS-CoV-2 infection (HSP47+ P<0.05 versus nonfibrotics and P<0.001 versus controls). Because HSP47+ cells are consistent with myofibroblasts, subjects with hot spots are termed "profibrotic." The remaining 60% of subjects dying with COVID-19 without hot spots are referred to as "nonfibrotic." No control subject exhibited hot spots. Conclusions Colocalization of myofibroblasts, M2(CD163+) macrophages, and collagen α 1(l) may be the first evidence of a COVID-19-related "profibrotic phenotype" in human hearts in situ. The potential public health and diagnostic implications of these observations require follow-up to further define mechanisms of viral-mediated cardiac fibrosis.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction

